enVVeno Medical (NVNO) Return on Capital Employed (2018 - 2026)

enVVeno Medical's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 77.89% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 2126.0% year-over-year to 77.89%; the TTM figure through Mar 2026 stood at 77.89% (down 2126.0% YoY), while the FY2025 annual figure was 59.48%, down 618.0% from the prior year.
• Return on Capital Employed was 77.89% for Q1 2026 at enVVeno Medical, down from 72.48% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 35.51% in Q1 2022 to a low of 90.59% in Q3 2023.
• Historically, Return on Capital Employed has averaged 63.28% across 5 years, with a median of 59.32% in 2022.
• The sharpest annual moves came in 2022 and 2024: Return on Capital Employed sank 3491 bps in 2022, then soared 3675 bps in 2024.
• A 5-year view of Return on Capital Employed shows it stood at 59.32% in 2022, then dropped by 15 bps to 68.22% in 2023, then gained by 23 bps to 52.28% in 2024, then slumped by 39 bps to 72.48% in 2025, then dropped by 7 bps to 77.89% in 2026.
• The last three Return on Capital Employed figures came in at 77.89% (Q1 2026), 72.48% (Q4 2025), and 73.55% (Q3 2025), per Business Quant data.